• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用预加热步骤对阴道自采样本进行分析,可提高 Aptima HPV 检测的 HPV 检出率。

Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay.

机构信息

Department of Obstetrics & Gynecology, Skåne University Hospital, Lund University, Lund, Sweden.

Department of Medical Microbiology, Laboratory Medicine Region Skåne, Lund University, Lund, Sweden.

出版信息

J Virol Methods. 2019 Aug;270:18-20. doi: 10.1016/j.jviromet.2019.04.015. Epub 2019 Apr 16.

DOI:10.1016/j.jviromet.2019.04.015
PMID:31002831
Abstract

BACKGROUND

We recently reported a sensitivity of 85.5% to detect high-grade squamous intraepithelial lesions (HSIL)/adenocarcinoma in situ (AIS)/cancer by the use of self-collected vaginal samples analysed by the Aptima mRNA HPV assay (AHPV).

OBJECTIVES

To increase detection of HPV among self-samples.

STUDY DESIGN

We used a pre-heating step at 90 °C for 1 h on our previously AHPV-negative self-samples (N = 20) among women with AHPV-positive cervical samples. We also analysed AHPV results before and after the heating among a series of self-samples from women who had not attended cervical screening for > 7 years (N = 173).

RESULTS

After heating, 55% (11/20) of the self-samples became AHPV-positive. By updating our original series 93.1% (121/130, 95% CI: 87.3-96.8) of the self-samples were AHPV-positive among women with AHPV-positive cervical samples, and among women with histologically confirmed cervical intraepithelial neoplasia or worse (CIN2+) now 95.3% (61/64, 95% CI: 86.9-99.0) of the self-samples were AHPV-positive. Among the 11 AHPV-positive self-samples we detected high-risk HPV types in 10 of the samples (HPV16 3 cases, HPV18 1, HPV31 1, HPV33 1, HPV 45 1, HPV51 2, HPV 56 and 58 1, HPV42 and 90 1 [low risk]) by multiplex PCR and Luminex assay. Among the self-samples from the non-attenders 16% (27/170) and 5.3% (8/152) were AHPV-positive after and before the heating step, respectively (P = 0.0022). Concerning validity of AHPV-results, 99% (170/172) were valid after the heating step compared to 88% (152/172) before the heating step (P < 0.0001).

CONCLUSIONS

A pre-heating step on vaginal self-samples increased HPV detection by the AHPV assay.

摘要

背景

我们最近报道了使用 Aptima mRNA HPV 检测(AHPV)分析的自我采集阴道样本检测高级别鳞状上皮内病变(HSIL)/原位腺癌(AIS)/癌的灵敏度为 85.5%。

目的

提高自我样本中 HPV 的检测率。

研究设计

我们对之前 AHPV 阴性的自我样本(N=20)进行了 90°C 预热 1 小时,这些自我样本来自 AHPV 阳性的宫颈样本。我们还分析了未参加宫颈筛查超过 7 年的 173 例自我样本(N=173)中 AHPV 检测结果在加热前后的变化。

结果

加热后,55%(11/20)的自我样本 AHPV 检测呈阳性。通过更新我们的原始系列,93.1%(121/130,95%CI:87.3-96.8)的自我样本在 AHPV 阳性的宫颈样本中 AHPV 检测呈阳性,在组织学证实的宫颈上皮内瘤变或更高级别病变(CIN2+)的女性中,现在 95.3%(61/64,95%CI:86.9-99.0)的自我样本 AHPV 检测呈阳性。在 11 例 AHPV 阳性的自我样本中,我们通过多重 PCR 和 Luminex 检测在 10 例样本中检测到高危 HPV 型(HPV16 3 例,HPV18 1 例,HPV31 1 例,HPV33 1 例,HPV45 1 例,HPV51 2 例,HPV56 和 58 1 例,HPV42 和 90 1 例[低危])。在未参加者的自我样本中,加热后分别有 16%(27/170)和 5.3%(8/152)的样本 AHPV 检测呈阳性(P=0.0022)。关于 AHPV 检测结果的有效性,加热后 99%(170/172)的结果有效,而加热前为 88%(152/172)(P<0.0001)。

结论

对阴道自我样本进行预热可提高 AHPV 检测的 HPV 检测率。

相似文献

1
Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay.使用预加热步骤对阴道自采样本进行分析,可提高 Aptima HPV 检测的 HPV 检出率。
J Virol Methods. 2019 Aug;270:18-20. doi: 10.1016/j.jviromet.2019.04.015. Epub 2019 Apr 16.
2
Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.在因巴氏细胞学检查发现意义不明确的非典型鳞状细胞而转诊进行阴道镜检查的女性人群中,比较Aptima人乳头瘤病毒检测法与cobas人乳头瘤病毒检测法检测人乳头瘤病毒的情况。
J Clin Microbiol. 2015 Apr;53(4):1277-81. doi: 10.1128/JCM.03558-14. Epub 2015 Feb 4.
3
HPV genotyping and E6/E7 transcript assays for cervical lesion detection in an Asian screening population-Cobas and Aptima HPV tests.HPV 基因分型和 E6/E7 转录物检测在亚洲筛查人群中用于宫颈病变检测——Cobas 和 Aptima HPV 检测。
J Clin Virol. 2018 Dec;109:13-18. doi: 10.1016/j.jcv.2018.10.004. Epub 2018 Oct 13.
4
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.德国两项连续筛查轮次、间隔 6 年的研究中,基于 RNA 的 Aptima 人乳头瘤病毒(AHPV)检测与基于 DNA 的杂交捕获 2 型 HPV 检测的纵向临床性能比较。
J Clin Microbiol. 2019 Jan 2;57(1). doi: 10.1128/JCM.01177-18. Print 2019 Jan.
5
The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.Aptima人乳头瘤病毒检测法对非典型鳞状细胞意义不明确(ASC-US)女性高危型人乳头瘤病毒检测的可靠性
J Clin Virol. 2015 Aug;69:52-5. doi: 10.1016/j.jcv.2015.05.006. Epub 2015 May 11.
6
Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.采用 mRNA 人乳头瘤病毒检测和肉眼观察对宫颈癌进行初级筛查和分流。
Int J Gynecol Cancer. 2013 Mar;23(3):513-8. doi: 10.1097/IGC.0b013e318280f3bc.
7
Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I.人乳头瘤病毒信使 RNA 检测在宫颈癌筛查中的应用:深圳宫颈癌筛查试验 I 期研究。
Int J Gynecol Cancer. 2010 Nov;20(8):1411-4. doi: 10.1111/IGC.0b013e3181f29547.
8
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.德国30至60岁女性常规筛查人群中基于RNA的Aptima人乳头瘤病毒(HPV)检测与基于DNA的杂交捕获2 HPV检测的直接比较
J Clin Microbiol. 2015 Aug;53(8):2509-16. doi: 10.1128/JCM.01013-15. Epub 2015 May 27.
9
Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.APTIMA HPV E6/E7 mRNA 检测与杂交捕获 2 型 HPV DNA 检测在 396 例经活检证实的宫颈癌中检测高危型致癌人乳头瘤病毒的比较敏感性。
J Med Virol. 2016 Jul;88(7):1271-8. doi: 10.1002/jmv.24453. Epub 2016 Jan 6.
10
Age-specific performance of human papillomavirus E6/E7 mRNA assay versus cytology for primary cervical cancer screening and triage: community-based screening in China.基于人群的中国宫颈癌筛查项目中,人乳头瘤病毒 E6/E7mRNA 检测与细胞学检查用于宫颈癌初筛和分流的年龄特异性表现
Front Cell Infect Microbiol. 2024 Aug 29;14:1428071. doi: 10.3389/fcimb.2024.1428071. eCollection 2024.

引用本文的文献

1
HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.HPValidate——在宫颈筛查中对自行采集样本进行DNA和mRNA检测的人乳头瘤病毒检测:三种自行采样装置的检测特征比较
Br J Cancer. 2025 Jul 8. doi: 10.1038/s41416-025-03102-5.
2
Human papillomavirus self-sampling with mRNA testing benefits routine screening.人乳头瘤病毒 mRNA 检测的自我采样有益于常规筛查。
Int J Cancer. 2022 Dec 1;151(11):1989-1996. doi: 10.1002/ijc.34170. Epub 2022 Jun 28.
3
High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
南非比勒陀利亚一家三级医院妇科诊所就诊的女性中,与医护人员采集的宫颈样本相比,其自行采集的阴道样本中高危型人乳头瘤病毒的检出率。
Virol J. 2021 Sep 23;18(1):192. doi: 10.1186/s12985-021-01662-5.
4
Self-Collection for Cervical Screening Programs: From Research to Reality.子宫颈癌筛查项目的自我采样:从研究到现实
Cancers (Basel). 2020 Apr 24;12(4):1053. doi: 10.3390/cancers12041053.
5
Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection.通过阴道自我采集样本检测高危型人乳头瘤病毒(hr-HPV)mRNA对长期未参加筛查人群进行宫颈癌预防
Infect Agent Cancer. 2020 Feb 13;15:10. doi: 10.1186/s13027-020-00280-0. eCollection 2020.